Official announcements
Search narrowed by
messages in brief
|
17/10/2014
Status 06.09.2014: The BASG / AGES Medical Market Surveillance became aware that dubious persons were contacting by telephone in the name of AGES pharmaceutical companies, or that these persons were posing as AGES employees in order to request…
Safety warnings
|
messages in brief
|
25/09/2014
Auto-injectors containing adrenaline are used for emergency treatment of anaphylactic shock or allergic reaction (e.g. to insect stings or bites, food or drugs). The active substance in the auto-injector (pen) is adrenaline, a substance that…
Safety warnings
|
messages in brief
|
17/09/2014
Situation EU: In addition to individual cases of manipulated, parallel distributed Italian Herceptin, manipulated, parallel distributed MabThera of Romanian origin has now occurred in Germany (as of 16.9.2014) The Paul Ehrlich Institute warns of…
messages in brief
|
01/09/2014
The Federal Criminal Police Office, in cooperation with AGES, today struck a decisive blow against an international drug counterfeiting ring.
messages in brief
|
28/07/2014
Reassessment completed with regard to higher body weight or BMI.
messages in brief
|
24/06/2014
Implementing regulation adopted for a common logo for online pharmacies to verify authenticity under the Falsified Medicines Directive.
Safety warnings
|
messages in brief
|
04/06/2014
Update on stolen vials of Herceptin and other products, newly affected: Avastin and MabThera
Safety warnings
|
messages in brief
|
30/05/2014
The BASG dissociates itself from statements on the homepage of the manufacturer of the unapproved drug "Reniale
Safety warnings
|
messages in brief
|
30/04/2014
European Commission orders withdrawal of approval for metoclopramide-containing medicines in drop form with a concentration higher than 1 mg/ml.
Safety warnings
|
messages in brief
|
25/04/2014
Questions and answers about the stolen vials of Herceptin and other affected products